Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. AMIX
10. Z

Go back to Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
(NASDAQ: AZYO) Delayed: 1.49 --0 (-0%)
Previous Close $1.49    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $1.49    P/E N/A 
Day Low $1.49    EPS $ 
Volume 33,510       

(NASDAQ: ELUT) Delayed: 1.06 +0.07 (7.07%)
Previous Close $0.99    52 Week High $ 
Open $1.00    52 Week Low $ 
Day High $1.06    P/E N/A 
Day Low $1.00    EPS $ 
Volume 173,080